Hutch News

Stories tagged Marco Mielcarek

Oncology Insights with Dr. Petros Grivas - Episode 16

Oncology Insights with Dr. Petros Grivas - Episode 16

Dr. Marco Mielcarek on making blood and marrow transplants safer and more accessible
Hutch NewsJune 16, 2026
Improving blood stem cell transplantation outcomes by treating donors

Improving blood stem cell transplantation outcomes by treating donors

From the Mielcarek Group, Clinical Research Division
Science SpotlightOctober 16, 2023
Fred Hutch blood and marrow transplant program recognized nationally for patient survival outcomes

Fred Hutch blood and marrow transplant program recognized nationally for patient survival outcomes

Industry data report shows Fred Hutch among 6.3% of U.S. transplant centers to exceed outcomes expectations
News ReleasesFebruary 06, 2023
Innovative approaches to lymphoma: clinical trials including CAR T-cell therapy, transplant, bispecific antibodies, novel kinase and checkpoint inhibitors

Innovative approaches to lymphoma: clinical trials including CAR T-cell therapy, transplant, bispecific antibodies, novel kinase and checkpoint inhibitors

Blog PostsJuly 17, 2020
SCCA Bone Marrow Transplant Program Survival Rates Recognized Nationally

SCCA Bone Marrow Transplant Program Survival Rates Recognized Nationally

News ReleasesDecember 18, 2018
Seattle Cancer Care Alliance Survival Rates Among Top in U.S. for Fred Hutch Bone Marrow Transplant Program at SCCA

Seattle Cancer Care Alliance Survival Rates Among Top in U.S. for Fred Hutch Bone Marrow Transplant Program at SCCA

News ReleasesJanuary 17, 2018
Seattle Cancer Care Alliance – Fred Hutch Transplant Survival Rates Among Best in U.S.

Seattle Cancer Care Alliance – Fred Hutch Transplant Survival Rates Among Best in U.S.

News ReleasesDecember 20, 2016